Clinical Pediatric Pneumonia Score in Critically Ill Children
NCT ID: NCT02139384
Last Updated: 2017-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2012-08-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Protocol Validation to Identify Prognostic Markers for Critical Care Pediatric Patients
NCT00792883
5 Years Mortality-rate in Patients Treated for Severe Pneumonia in an ICU - a Retrospective Study
NCT02212093
Predictors of Acute Kidney Injury in Critically Ill Children Admitted to PICU.
NCT06328478
Use of Simplified Lung Ultrasound Score for Predicting ICU Outcomes in Patients with Acute Respiratory Failure
NCT06678035
Adaptation of a Premorbid Function Scoring System as a Predictor for Intensive Care Unit Mortality
NCT02386254
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 1 day to 21 years
* Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months
* Have received antibiotics for less than 12 hours
* Have been intubated for less than 24 hours
* Patients must be English or Spanish speaking for consent purposes.
Exclusion Criteria
* Patients who have been intubated for greater than 24 hours
* Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage
1 Day
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Loma Linda University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cynthia Tinsley, M.D.
Role: PRINCIPAL_INVESTIGATOR
Loma Linda University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University Children's Hospital
Loma Linda, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5110327
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.